RNAZ

Conviction 20HealthcareScan · Thu, Jun 25, 2026

RNAZ$4.47-8.68%

ResistanceSupportVol 14

Vol MA14 92.95K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Transcode Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.transcodetherapeutics.com ↗

Price4.47

Change-8.68%

Gap+0.10%

Rel volume6.39×

Avg volume190.93K

Avg $ vol946.35K

SMA 205.23

SMA 506.41

SMA 2008.94

Price vs 50-30.29%

Price vs 200-50.00%

MA stackbearish

50/200 cross—

Supertrendup · 4.01

RSI (14)37

MACD hist0.00

MACD cross—

Stoch %K / %D6 / 25

ADX (14)13

+DI / −DI21 / 29

RSI divergence—

MACD divergenceBullish

ATR %+16.35%

ADR %13.15%

52w high15.23

52w low0.0000

From 52w high-70.65%

Above 52w low—

New 52w highNo

SqueezeOn · 13d

Bollinger width26.05%

%B-0.06

Donchian pos26.21%

Donchian high6.30

Donchian low3.82

AVWAP (52w high)10.96

vs AVWAP high-59.21%

AVWAP (52w low)8.82

vs AVWAP low-49.33%

OBV trendDown

Chaikin MF (20)0.16

Today vs 20d6.39×

Avg vol (14d)92.95K

Avg vol (20d)190.93K

Avg $ vol (20d)946.35K

Market cap4.25M

RS 3m (vs SPY)-54.74%

RS 6m (vs SPY)-45.93%

RS line new highNo

Trend template0/8

Technical rank8.3

1 week-16.45%

1 month-17.07%

3 months-47.66%

6 months-41.15%

1 year-42.62%

YTD-39.59%

P/E-0.12

P/B3.39

P/S—

P/FCF-0.22

EPS-52.59

Div yield—

ROE—

ROA-22.05%

Debt/Eq—

Current3.11

EV/EBITDA0.31

Gross margin—

Net margin—

Rev growth—

EPS growth-106.87%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-8.59M

Revenue—

Net income-17.79M

Gross profit—

Free cash flow-19.52M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out950.3K

Employees12

ListedFri, Jul 9, 2021

Free float832.61K

Float %90.8%

Short interest28.14K

Days to cover1.9d

Short volume33.6%

Squeeze score31 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank8.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance7.40

Support4.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RNAZ

All disclosures →

No recent disclosed trades by Congress in RNAZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RNAZ

No recent insider (Form 4) filings in RNAZ. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in RNAZ · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.